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Abstract The tumor suppressor p53 is degraded by the
ubiquitin-proteasome system. p53 was polyubiquitinated in the
presence of E1, UbcH5 as E2 and MDM2 oncoprotein. A
ubiquitin molecule bound MDM2 through sulfhydroxy bond
which is characteristic of ubiquitin ligase (E3)-ubiquitin binding.
The cysteine residue in the carboxyl terminus of MDM2 was
essential for the activity. These data suggest that the MDM2
protein, which is induced by p53, functions as a ubiquitin ligase,
E3, in human papillomavirus-uninfected cells which do not have
E6 protein.
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1. Introduction
The p53 tumor suppressor gene product exerts antiprolifer-
ation e¡ects including growth arrest, genetic stability and
apoptosis [1]. p53 exhibits DNA binding activity and func-
tions as a transcription factor. The protein induces the expres-
sion of genes (GADD45, WAF1/p21/CIP1, cyclinG, Bax and
MDM2) [2^6] regulating cell cycle arrest and apoptosis. In
normal cells, p53 is maintained at very low, often undetectable
levels. The level of p53 increases, in response to various types
of stress and the inhibition of its degradation is one of the
mechanism of this increase. p53 degradation is regulated by
the ubiquitin-proteolysis system [7]. In cells infected with hu-
man papillomavirus, HPV16 or HPV18, papillomavirus E6
and cellular E6-AP form a complex and function as ubiquitin
ligase, E3 for p53 [8]. In uninfected cells, however, E6-AP
functions as ubiquitin ligase, not for p53, but for HHR23A
without E6 [9]. Since tight regulation of p53 seems critical not
only for various forms of stress response but also for normal
cell growth and genetic stability, the ubiquitin ligase for p53 is
of intense interest.
GADD45, WAF1/p21/CIP1, cyclinG, Bax and MDM2 are
identi¢ed as target genes of p53 [2^6]. Except for MDM2 [10],
the expression of these genes is immediately induced after
induction of p53. The expression of MDM2 increases at least
one hour later than the induction of p53. The MDM2 protein
has the ability to bind p53 and has been thought to suppress
the activity of p53 as the transcription factor by interacting
with p53 in its transcriptional activation domain in the N-
terminal region [11]. Furthermore, recent reports show that
MDM2 accelerates p53 degradation [12,13], although the
mechanism of the degradation has not been clari¢ed.
In the ubiquitin-proteolysis system, the ubiquitin-protein
adduct is formed in three sequential steps [14] which contain
the ubiquitin activating enzyme, E1, the ubiquitin conjugating
enzyme, E2 and the ubiquitin ligase, E3. E1 is a common
enzyme involved in all kinds of ubiquitination. The speci¢city
of the targeted protein is dependent on the E2 and E3 used in
the reaction. The resultant ubiquitinated protein is degraded
by proteasome.
2. Materials and methods
2.1. Expression of proteins
Human MDM2 [15], E6-AP [16], UbcH7 [17], E2-C/UbcH10 [18],
EFP [19], cdc34 [20] and UbcH5 [21] cDNAs were obtained by RT-
PCR using RNA from HeLa S3 cells. E6 cDNA was ampli¢ed from
the prototype HPV16 genome. Each cDNA of human p53, MDM2,
E6-AP and E6 was inserted into a GST-fused or 6UHis pFastBac
vector (GIBCO) and the proteins expressed in Sf9 cells in accordance
with the manufacturer’s protocol. Each E2 (UbcH7, E2-C/UbcH10,
EFP, cdc34 and UbcH5) was ligated into a pET3 vector and expressed
in Escherichia coli BL [21]. Baculovirus expressed mouse E1 [22] pro-
tein was puri¢ed by ubiquitin a⁄nity column. In some experiments,
GST-p53 and GST-MDM2 were puri¢ed by use of glutathione se-
pharose 4B resin.
2.2. In vitro ubiquitination assay
The reaction mixture (50 Wl) contained Sf9 cell extract expressing
GST-p53 (500 ng), mouse E1 (500 ng), E2 (500 ng), biotinylated
ubiquitin (15 Wg) and MDM2 (500 ng), 50 mM Tris-HCl (pH 7.4),
5 mM MgCl2, 2 mM ATP and 2 mM dithiothreitol (DTT). When the
cell extract was used, it was prepared from HeLa S3 cells (1U105
cells) at the log phase or aphidicolin treated G1/S phase. After incu-
bation at 25‡C for 30 min, the GST-p53 was pulled down with glu-
tathione sepharose 4B resin (Pharmacia) and resolved by SDS-7.5%
PAGE. The proteins in the gel were transferred to a PVDF membrane
(Millipore). The membrane was incubated with ExtrAvidin peroxidase
(Sigma) at room temperature for 1 h and washed. Then the ubiquiti-
nated proteins were visualized by ECL (Amersham).
2.3. Thioester formation assay
The reaction mixture (50 Wl) containing Sf9 cell extract expressing
GST-MDM2, UbcH5, E1 and biotinylated ubiquitin, 50 mM Tris-
HCl (pH 7.4), 5 mM MgCl2, 2 mM ATP and 0.2 mM DTT was
incubated at 25‡C for 5 min. The GST-MDM2 was pulled down
with glutathione sepharose 4B resin and then treated with SDS-
PAGE/sample bu¡er with (+) or without (3) 100 mM DTT. The
DTT(3) sample bu¡er contained 4 M urea. DTT(+) samples were
boiled for 5 min and DTT(3) samples were incubated at 30‡C for
15 min prior to SDS-7.5% PAGE. The following steps were performed
as described in Section 2.2.
3. Results and discussion
When GST-p53 is incubated with MDM2 and various
kinds of E2, multiple ubiquitination of p53 was detected using
UbcH5 as E2 (Fig. 1A, B). When other kinds of E2 were used,
the ubiquitination of p53 was not detected. The polyubiquiti-
nated adducts of p53 were also detected using E6/E6-AP as
described previously [8]. Though the ubiquitination of cyclin
B or Cut2 required HeLa cell extract as the source of cyclo-
some/APC in this in vitro ubiquitination system [23] (Tanaka,
H., Miyauchi, Y. and Yasuda, H., unpublished results), the
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multiple ubiquitination of p53 was observed without HeLa
cell extract (Fig. 2A). Furthermore, when puri¢ed p53 and
MDM2 were used to remove the e¡ect of proteins originated
from sf9 cell lysate, the polyubiquitination of p53 was still
detected (Fig. 2B).
A ubiquitination of MDM2 was also detected in the pres-
ence of UbcH5 and was sensitive to dithiothreitol, indicating
that the bond between MDM2 and ubiquitin is thioester (Fig.
3). This indicated that the ubiquitin molecule bound MDM2
through a sulfhydroxy bond which was characteristic of ubiq-
uitin ligase (E3)-ubiquitin binding [24].
The E3 has been thought to contain the HECT (homolo-
gous to the E6-AP carboxyl terminus) domain in the carboxyl
terminus. The carboxyl terminal peptide of MDM2 was com-
pared to the HECT domain [25] (Fig. 4A). The identical ami-
no acid residues are shown by asterisks in Fig. 4A, showing
the homology of this region to HECT to be very weak. The
cysteine, shown in bold, has been thought to be the essential
residue for E3 having a HECT domain. A ubiquitin is thought
to bind this cysteine through sulfhydroxy bond. Whether or
not the correspondent cysteine residue of MDM2 was essen-
tial for its ligase activity was tested for. When the residue was
mutated to alanine, the mutated MDM2 (C464A) did not
have ubiquitin ligase activity (Fig. 4B).
As shown above, the multiple ubiquitination of p53 was
detected using UbcH5 as E2 (Fig. 1). Although we did not
use Ubc4 in this experiment, Ubc4 was thought to work as
UbcH5 in this reaction, because the Ubc4 was highly homol-
ogous to UbcH5. Although the ubiquitination of p53 was
detected in the presence of puri¢ed MDM2, it can not be
denied that a small amount of the protein(s) or low molecular
weight substance(s) originating from sf9 cell extract was nec-
essary in this reaction. The data shown here, however, clearly
show that the MDM2 had catalytic activity of ubiquitin li-
gase, E3, for p53.
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Fig. 2. MDM2-dependent ubiquitination of p53 in the absence of
cell extract. The reaction was performed as described in A using
UbcH5 as E2, in the absence (lane 1, 2) or presence of HeLa cell
extract (log phase: lane 3, 4, G1/S phase: lane 5, 6). B: Ubiquitina-
tion assay using puri¢ed p53 and MDM2 [15]. SDS-12.5% PAGE
of the puri¢ed GST-p53 and MDM2 (lane 7 and 8, respectively)
was stained with coomasie brilliant blue R-250. Glutathione sephar-
ose 4B resin conjugated with GST-p53 was incubated with (lane 10,
11) or without (lane 9) puri¢ed MDM2. In the absence of UbcH5
(lane 11), polyubiqutinated p53 was not detected.
Fig. 3. Thioester formation of MDM2. Baculovirus expressed GST-
MDM2 was incubated with UbcH5, E1 and biotinylated ubiquitin.
After incubation, GST-MDM2 was pulled down with glutathione
sepharose 4B resin (Pharmacia) and the reaction terminated by ad-
dition of SDS/PAGE sample bu¡er containing (lane 1, 2) or not
containing (lane 3, 4) 100 mM DTT. The ubiquitin thioester forma-
tion on MDM2 was dependent upon the presence of UbcH5.
Fig. 1. Ubiquitination of p53 by MDM2 in vitro. A: MDM2 co-op-
erates for the ubiquitination of p53 with UbcH5. GST human p53,
6UHis-human MDM2 and 6UHis-E6/E6-AP protein were expressed
in Sf9 cells. Sf9 cell extracts expressing GST-p53 were incubated
with E1, E2, biotinylated ubiquitin and HeLa cell extract in the
presence (lane 2, 4, 6, 8 and 10) or absence (lane 1, 3, 5, 7 and 9)
of MDM2. As a control, E6/E6-AP was used instead of MDM2
(lane 11). The ubiquitin onjugating enzyme E2s, UbcH7 (lane 1, 2),
E2-C/UbcH10 (lane 3, 4), EFP (lane 5, 6), cdc34 (lane 7, 8) and
UbcH5 (lane 9^11) were expressed in E. coli. B: The membrane
used in A was stained by amido black, and the multiubiquitinated
ladders of p53 were detected in lane 10 and 11.
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The MDM2 has ubiquitin ligase activity for p53 and only a
very low homology to the HECT domain. MDM2 itself binds
p53 and E6-AP cannot bind p53 without E6. MDM2 binds to
p53 through its N-terminal domain and there are several
phosphorylated residues in the domain. Phosphorylation was
catalyzed by DNA-dependent protein kinase or casein kinase
I, and the e¡ects of the phosphorylation on MDM2 E3 activ-
ity are interesting subjects that need to be clari¢ed.
MDM2 is expressed later than other induced genes by p53
after DNA damage. This suggests that p53 expression induced
by DNA damage is regulated by auto-feedback via the ubiq-
uitin-proteolysis system using MDM2 as E3 [26,27].
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Fig. 4. Cysteine in the carboxyl terminal region of MDM2 is essen-
tial for the ubiquitin ligase activity. A: Comparison of amino acid
sequence between the carboxyl terminal peptide of human MDM2
and the HECT domain of E6-AP. The identical amino acid residues
are shown by asterisks. The cysteine shown in bold was the essential
residue of the E3 with a HECT domain. B: The mutated MDM2
(C464A) did not have ubiquitin ligase activity. The ubiquitination
assay was performed as described in Fig. 1 without MDM2 (lane
1), with mutated MDM2 (C464A) (lane 2) and with wild-type
MDM2 (lane 3).
R. Honda et al./FEBS Letters 420 (1997) 25^27 27
